Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketek (telithromycin) in Respiratory Tract Infections
NCT00261105Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2005
- Primary completion
- Oct 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 4 trial of telithromycin in community acquired pneumonia (CAP), Chronic Bronchitis With Acute Bacterial Exacerbation, acute sinusitis, sponsored by Sanofi. Started Feb 2005; status: completed.
02
Drugs
telithromycin
03
Conditions
community acquired pneumonia (CAP)Chronic Bronchitis With Acute Bacterial Exacerbationacute sinusitis
Beyond the preview
Go deeper on NCT00261105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261105.